IEL Limited (BOM:524614)
4.610
+0.040 (0.88%)
At close: Jul 28, 2025
Blueprint Medicines Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 252.19 | 4.09 | 9.11 | 2.04 | 0.57 | Upgrade |
Cash & Short-Term Investments | 252.19 | 4.09 | 9.11 | 2.04 | 0.57 | Upgrade |
Cash Growth | 6070.00% | -55.12% | 347.31% | 256.65% | -90.68% | Upgrade |
Accounts Receivable | 0.08 | 16.56 | 22.86 | 5.03 | 3.01 | Upgrade |
Other Receivables | - | - | - | - | 0.11 | Upgrade |
Receivables | 211.37 | 19.9 | 23.11 | 8.73 | 3.14 | Upgrade |
Inventory | - | 10.15 | - | - | - | Upgrade |
Prepaid Expenses | - | 0.02 | 0.05 | - | 0.09 | Upgrade |
Other Current Assets | 4.97 | 1.57 | 0.94 | 0.36 | 0.28 | Upgrade |
Total Current Assets | 468.53 | 35.72 | 33.2 | 11.13 | 4.09 | Upgrade |
Property, Plant & Equipment | 0.54 | 1.73 | 2.03 | 35.31 | 36.22 | Upgrade |
Long-Term Deferred Tax Assets | 0.15 | 0.14 | 0.13 | - | - | Upgrade |
Other Long-Term Assets | - | -0 | 0 | - | 0.08 | Upgrade |
Total Assets | 469.22 | 37.59 | 35.36 | 46.44 | 40.39 | Upgrade |
Accounts Payable | 4.5 | 15.41 | 16.52 | 0.15 | 1.41 | Upgrade |
Accrued Expenses | 1.47 | 0.94 | 0.17 | 0.68 | 1.66 | Upgrade |
Other Current Liabilities | 0.98 | 0 | - | 5.1 | - | Upgrade |
Total Current Liabilities | 6.95 | 16.35 | 16.69 | 5.93 | 3.07 | Upgrade |
Long-Term Debt | 9 | 9 | 9 | 9.11 | 9.11 | Upgrade |
Other Long-Term Liabilities | 5 | - | 0 | 10.66 | 10.66 | Upgrade |
Total Liabilities | 20.95 | 25.35 | 25.69 | 25.7 | 22.84 | Upgrade |
Common Stock | 130.39 | 33.38 | 33.38 | 33.38 | 33.38 | Upgrade |
Additional Paid-In Capital | - | 19.48 | 19.48 | 19.48 | 19.48 | Upgrade |
Retained Earnings | - | -41.47 | -44.04 | -67.7 | -71.71 | Upgrade |
Comprehensive Income & Other | 317.88 | 0.85 | 0.85 | 35.59 | 36.41 | Upgrade |
Total Common Equity | 448.27 | 12.24 | 9.67 | 20.75 | 17.55 | Upgrade |
Shareholders' Equity | 448.27 | 12.24 | 9.67 | 20.75 | 17.55 | Upgrade |
Total Liabilities & Equity | 469.22 | 37.59 | 35.36 | 46.44 | 40.39 | Upgrade |
Total Debt | 9 | 9 | 9 | 9.11 | 9.11 | Upgrade |
Net Cash (Debt) | 243.19 | -4.91 | 0.11 | -7.07 | -8.54 | Upgrade |
Net Cash Per Share | 1.86 | -0.15 | 0.00 | -0.21 | -0.26 | Upgrade |
Filing Date Shares Outstanding | 127.41 | 33.38 | 33.38 | 33.38 | 33.38 | Upgrade |
Total Common Shares Outstanding | 127.41 | 33.38 | 33.38 | 33.38 | 33.38 | Upgrade |
Working Capital | 461.58 | 19.37 | 16.51 | 5.2 | 1.02 | Upgrade |
Book Value Per Share | 3.52 | 0.37 | 0.29 | 0.62 | 0.53 | Upgrade |
Tangible Book Value | 448.27 | 12.24 | 9.67 | 20.75 | 17.55 | Upgrade |
Tangible Book Value Per Share | 3.52 | 0.37 | 0.29 | 0.62 | 0.53 | Upgrade |
Land | - | 14.99 | 14.99 | 49.4 | 49.4 | Upgrade |
Buildings | - | 0.75 | 0.75 | 1.02 | 1.02 | Upgrade |
Machinery | - | 7.46 | 7.44 | 5.37 | 8.1 | Upgrade |
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.